3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
7
Phantoms, Imaging
7
Cyclophosphamide
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
fludarabine
4
Etoposide
4
Biopsy
4
tazemetostat
3
etoposide phosphate
3
Vincristine
3
Temozolomide
3
Nivolumab
3
Cisplatin
3
Carboplatin
3
Automobiles
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Topotecan
2
Sirolimus
2
Methotrexate
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Dasatinib
×
1 year
×
Clear all
No trials found.